Opendata, web and dolomites

METAdiag

METAdiag: Diagnose to Cure

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 METAdiag project word cloud

Explore the words cloud of the METAdiag project. It provides you a very rough idea of what is the project "METAdiag" about.

diagnosis    appear    organisms    feed    lifelong    serious    cancer    mechanism    detect    impacts    initially    progress    clinicians    proprietary    metabolic    conduct    metadiag    small    consumption    metafora    as    poorer    cell    living    balanced    status    cells    damages    fact    errors    clinical    starting    financial    energetic    longer    damage    hire    boost    uniquely    economic    turn    conversely    burden    company    levels    expecting    impaired    inborn    reliability    correctly    positioned    despite    generate    transporters    subjects    quality    patients    prevent    surface    commercial    therapies    receive    impairments    abnormal    revenues    quantifying    diabetes    reverted    life    overlooked    symptoms    healthy    perspectives    onset    overfeeding    42    hallmark    function    entail    incur    metabolism    million    diet    earlier    monitor    prognosis    22    feasibility    market    stay    first    starving    treatments    milestones    diseases    invasive    tests    influencing    adapt    debilitating    time    people    detection    network    platform    diagnostic    accuracy    proving    nutrient    energetics   

Project "METAdiag" data sheet

The following table provides information about the project.

Coordinator
METAFORA BIOSYSTEMS 

Organization address
address: 29 RUE DU FAUBOURG SAINT JACQUES
city: PARIS
postcode: 75014
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.metafora-biosystems.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-02-01   to  2017-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    METAFORA BIOSYSTEMS FR (PARIS) coordinator 50˙000.00

Map

 Project objective

As all living organisms, our cells need to feed on a balanced diet to stay healthy and correctly function. To do that, cells adapt their nutrient consumption according to their energetic needs. If the uptake mechanism is impaired, it impacts cell metabolism. Both starving cells & overfeeding cells are a hallmark for the onset and progress of serious diseases like diabetes, cancer or inborn errors of metabolism, which can all be seen as metabolic diseases. These are debilitating conditions that need lifelong treatments, entail poorer life quality and incur a major economic burden. Subjects appear initially healthy and symptoms are often overlooked, but by the time of diagnosis, damage can no longer be reverted. Conversely, early detection could prevent most of the damages by starting specific therapies. However, despite the fact that all metabolic diseases have abnormal cell energetics, there are no tests for cell metabolism in clinical practice. In response, we at METAFORA aim to bring to market METAdiag, the first diagnostic platform able to assess and monitor the metabolic status of our cells. This unique and non-invasive diagnostic system is able to detect abnormal cell energetics by quantifying the levels of nutrient transporters at the cell surface. After proving the reliability and accuracy of our platform at a small scale, we now aim to take a step further towards the market. Thus, in Phase 1 we aim to conduct a Feasibility Study that will help us to assess and achieve the significant milestones influencing the project from the technical, commercial and financial perspectives. Based on proprietary technology and on a strong collaboration network, METAdiag will be uniquely positioned to detect metabolic impairments, allowing clinicians to achieve an earlier diagnosis and patients to receive better management and prognosis. In turn, METAdiag will boost the growth of our company, expecting to generate €42 million in revenues and to hire 22 new people in 5 years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "METADIAG" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "METADIAG" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

INTE-AFRICA (2019)

Integrating and decentralising diabetes and hypertension services in Africa

Read More